Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPICILLIN vs ANDEXANET ALFA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPICILLIN vs ANDEXANET ALFA: Safety Overview

Metric AMPICILLIN ANDEXANET ALFA
Total FAERS Reports 3,653 1,074
Deaths Reported 482 546
Death Rate 13.2% 50.8%
Hospitalizations 1,227 187
Average Patient Age 45.1 yrs 78.2 yrs
% Female Patients 65.6% 41.8%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Meitheal Pharmaceuticals Inc. AstraZeneca Pharmaceuticals LP
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued N/A